Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases

Medicine and Dentistry

• Dementia 100%
• Diseases 80%
• Biological Marker 60%
• Immune System 60%
• Autoimmunity 60%
• Mendelian Randomization Analysis 60%
• Blood Brain Barrier 40%
• Therapeutic Procedure 40%
• Hazard Ratio 20%
• Amyloid 20%
• Alzheimer's Disease 20%
• Genetic Background 20%
• Drug Screening 20%
• Methotrexate 20%
• Autoimmune Disease 20%
• Human Leukocyte Antigen 20%
• Development 20%
• Controlled Substance 20%
• Synuclein 20%
• Phenome 20%
• Analysis 20%
• Association 20%
• Incidence 20%
• Anti-Inflammatory Drug 20%

Biochemistry, Genetics and Molecular Biology

• Autoimmunity 60%
• Mendelian Randomization 60%
• Tau 40%
• Blood Brain Barrier 40%
• Amyloid 20%
• Electric Potential 20%
• Development 20%
• Methotrexate 20%
• Genetic Background 20%
• Synuclein 20%
• Drug Screening 20%
• Human Leukocyte Antigen 20%
• Association 20%
• Incidence 20%

Neuroscience

• Dementia 100%
• Blood Brain Barrier 40%
• Amyloid 20%
• Anti-Inflammatory 20%
• Autoimmune Disease 20%
• Methotrexate 20%
• Human Leukocyte Antigen 20%
• Synuclein 20%